key: cord-0331638-rtx6jpju authors: Li, Q.; Chen, L.; Jiang, H.; Zheng, D.; Wang, Y.; Mei, J.; Ma, X.; Wei, Y.; Zhao, Y.; Qiao, J. title: Clinical characteristics of pregnant women infected with Coronavirus Disease 2019 in China: a nationwide case-control study date: 2021-10-23 journal: nan DOI: 10.1101/2021.10.21.21265313 sha: 4b8cf81d7480e24abccbc98614f2830c32b77095 doc_id: 331638 cord_uid: rtx6jpju OBJECTIVE To formally compare the clinical course of Coronavirus disease 2019 (COVID-19) in pregnant women with their nonpregnant counterparts. METHODS Clinical data of pregnant women with confirmed COVID-19 in the designated hospitals of mainland China were retrieved up to April 12, 2020 through an epidemic reporting system maintained at the National Health Commission of the People's Republic China. Each pregnant patient was randomly matched to a nonpregnant woman with confirmed COVID-19 in the same hospital as control, then their clinical courses were formally compared. RESULTS 138 pregnant women had been identified as confirmed COVID-19 cases. Among them, 17 severe cases and 1 maternal death were recorded, which was less than their nonpregnant peers (23 severe cases and 3 death). 57.2% had been infected with SARS-CoV-2 during the third trimester, including 13 severe cases and 1 maternal death. 7.3% of pregnant patients had diarrhea and 3.6% had nausea or vomiting, compared with related proportion as 15.2% (OR: 0.38, 95%CI: 0.15, 0.96) and 10.1% (OR: 0.25, 95%CI: 0.07, 0.89) in nonpregnant patients. Pregnant patients infected with SARS-CoV-2 in early pregnancy presented similar laboratory tests with their nonpregnant peers, however, with pregnancy progresses, increased inflammation, coagulation and hepatic injury markers happened more and more frequently (p<0.001) in pregnant patients. CONCLUSIONS Being pregnant did not represent a risk for severe condition when compared with their nonpregnant peers. Patients infected with SARS-CoV-2 in early pregnancy were even at lower risk of severe illness than those infected in late pregnancy. Due to the high infectivity of severe acute respiratory syndrome coronavirus 2 73 (SARS-CoV-2), coronavirus disease 2019 (COVID-19) caused by the virus has spread 74 quickly in worldwide, and was declared by the World Health Organization (WHO) as 75 a Public Health Emergency of International Concern (PHEIC). Over the past six 76 months, more than 10 million confirmed cases of COVID-19 had been documented 77 globally, resulting in more than 500,000 deaths. 1 78 79 According to the previous studies which were relevant to severe acute respiratory 80 syndrome (SARS) and middle east respiratory syndrome (MERS), pregnant women 81 were more susceptible to coronavirus infection, and they were also at a high risk of 82 poor outcomes, including need for mechanical ventilation, admission to an intensive 83 care unit (ICU), renal failure and death. 2 Considering that SARS-CoV-2 has up to 80% 84 sequence similarity with SARS-CoV, 3 for SARS-CoV-2 on high throughput sequencing or real-time reverse transcriptase 144 polymerase chain reaction (RT-PCR) assay of nasal and pharyngeal swab specimens. 145 The degree of severity (severe and critical case) was classified by using the mentioned 146 guidance. Severe cases were defined as meeting one of these conditions: 1) 147 respiratory rate ≥ 30 breaths/min; 2) arterial oxygen tension (PaO 2 ) over inspiratory 148 oxygen fraction (FIO 2 ) of less than 300 mmHg; 3) Percutaneous oxygen saturation 149 (SpO 2 ) ≤ 93% on room air at rest. Critical cases were defined as on the following 150 conditions: 1) occurrence of severe respiratory distress; 2) respiratory failure requiring 151 mechanical ventilation; 3) shock and organ failure even needs of ICU care. 152 153 Continuous variables were expressed as medians and interquartile ranges (IQR). 155 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. SARS-CoV-2 in early pregnancy, pregnant patient infected in late pregnancy were 182 more likely to present reduced lymphocytes, hemoglobin, and albumin levels (p<0.05), 183 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 23, 2021. On admission, the median value of leukocyte counts was 6.5×10 9 /L among pregnant 201 patients, which was higher than that of nonpregnant patients (4. (Table S1 , S2 and S3 in appendix). We also found pregnant 210 patients had a lower level of hemoglobin and albumin than their nonpregnant peers 211 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Through the epidemic reporting system maintained at the NHCPRC, we recruited a 229 total of 138 pregnant women confirmed with COVID-19 across mainland China. By 230 analyzing their clinical characteristics, we found pregnant women tend to present less 231 symptom, had unique laboratory findings, and tend to at lower risk of 232 COVID-19-related death. Additionally, we also found patients infected with 233 SARS-CoV-2 in the early pregnancy tend to be in the less severe condition of illness 234 than those infected in late pregnancy. To our best knowledge, this is the first study 235 provide detailed information regarding SARS-CoV-2 infection in different gestation 236 as well as a formally comparison of the clinical course of COVID-19 between 237 pregnant women and nonpregnant women. These findings are essential for 238 understanding of COVID-19 and improving clinical guidance for management of 239 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In our study, we found the overall incidence of clinical symptoms during 242 hospitalization is lower than that of nonpregnant women, which is consistent with the 243 largest epidemic report of 3,474 pregnant COVID-19 patient from U.S. CDC 5 , as they 244 also indicated that pregnant women less frequently reported headache, muscle aches, 245 fever, chills, and diarrhea than did nonpregnant women. We further noted that the 246 incidence of gastrointestinal symptoms was significantly lower in pregnant women 247 than nonpregnant women, and it was also lower than that of the report of the U.S. 248 CDC (3.6% versus 19.6% had nausea or vomiting; 7.3% versus 14.3% had diarrhea). 5 The widely use of antiviral drugs may affect the incidence of gastrointestinal 250 symptoms such as nausea and vomiting, thus we had defined symptoms as the 251 incidence at admission to exclude the influence of this factor in the analysis, which 252 may contribute to the difference. Digestive symptoms imply that viral load and 253 replication within the gastrointestinal tract, which was associated with more severe 254 illness as studies had shown that COVID-19 patients without digestive symptoms are 255 more likely to be cured and discharged than patients with digestive symptoms. 9 These 256 findings suggested that signs and symptoms of COVID-19 might differ between 257 pregnant and nonpregnant women, which can also serve as evidence for the inference 258 that pregnant women tend to have mild illness than their nonpregnant peers. 259 With the physiological change during pregnancy, many laboratory indicators altered 261 gradually. Comparing to nonpregnant women, the serum albumin and hemoglobin 262 concentration decreases due to hemodilution; coagulation is augmented following 263 with an increased fibrinogen and D-dimer concentration in pregnant population. 10 264 Leukocyte counts increased and lymphocytes counts deceased as gestation proceeds 265 due to the gradual increase in neutrophils counts. 11 When compared pregnant patients 266 with their nonpregnent peers, consistent features were observed as we found 267 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 23, 2021. However, in the nationwide case-control study, we found being pregnant didn't 291 represent a risk for severity of clinical presentation and maternal death in 292 SARS-Cov-2 infection, which may be related to the special pathogenic mechanism of 293 SARS-Cov-2 and the unique pregnancy immune status of pregnant women. 14 In the 294 case of SARS-CoV infection, the immune response of Th1 type is highly activated 295 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 23, 2021. ; https://doi.org/10.1101/2021.10.21.21265313 doi: medRxiv preprint and lasts for a long time, resulting in a consistently high level of pro-inflammatory 296 cytokine expression, which may be responsible for extensive target organ damage. 15 For SARS-CoV-2 infection, the intensity and duration of Th2 immune responses were 298 similar with Th1, 13 which may mitigate pro-inflammatory cytokine expression and the 299 resulting organ damage. During pregnancy, the maternal immune system will make 300 real-time adjustments to resist the invasion of pathogens as well as to tolerate the 301 implantation of fetus and placenta. 16 18 19 which implied that the mild condition of pregnant women may 310 also associated with their lower exposure due to strengthen self-protection measures. 311 312 Among pregnant COVID-19 patients, we noted that patients infected with 313 SARS-CoV-2 in the late pregnancy tend to be in the more severe condition of illness 314 than those infected in early pregnancy, as 13 of the all 17 severe cases in our study 315 were infected in the late pregnancy (one of them had passed away), and a higher 316 proportion of pregnant patient infected in late pregnancy presented dyspnea who 317 needed oxygen support or even invasive mechanical ventilation. Higher oxygen 318 demands due to pregnancy-associated anatomical and physiological adaptive changes 319 (e.g., diaphragm elevation, increased oxygen consumption, incremental circulation 320 volume and edema of respiratory tract mucosa) in the cardio-respiratory system, 321 increased risk of pulmonary microvascular thrombosis due to pregnancy-associated 322 hypercoagulable state could all have an important role in the clinical course of 323 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. We also noted that a certain number of maternal deaths caused by COVID-19 were 326 reported by various country and regions. 5 21 22 According to the report of U.S. CDC, 327 there were 16 pregnant COVID-19 patients had passed away. They also reported that 328 pregnant patients were 1.5 times more likely to be admitted to the ICU (95% CI: 1.2, 329 1.8) and 1.7 times more likely to receive mechanical ventilation (95% CI: 1.2, 2.4) . 330 Another national study from Sweden also found that pregnant patients were 5 times 331 more likely to be admitted to the ICU and 4 times more like to receive mechanical 332 ventilation than were nonpregnant patients. 23 In our study collecting data up to the 333 April 12, 2020, only 1 maternal death at 35 days after delivery was recorded, which 334 was lower than that of nonpregnant patients. Pregnant patients in our study were also 335 less likely to be in the more severe condition of illness. Even not much was known 336 about the SARS-CoV-2 in early days of the pandemic, the high priority of prenatal 337 care, the effective performance of the maternal and child health care system, the The findings of present study also provide more reliable evidence towards the 346 management of pregnant women with COVID-19. For mild patients infected with 347 SARS-CoV-2 during early pregnancy, as being pregnant did not associate with 348 increased risk of severe illness, and the prognosis for most of them was favorable, we 349 had no evidence sufficient to terminate pregnancy in current stage. However, special 350 attention must be paid to patients infected with SARS-CoV-2 in the late pregnancy 351 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 23, 2021. ; https://doi.org/10.1101/2021.10.21.21265313 doi: medRxiv preprint since the risk of severe illness among them seems higher than that of patients infected 352 in early stage and a exacerbations of COVID-19 were observed in women during the 353 postpartum period. 6 While for severe or critical cases, it is necessary to take both 354 obstetrical situation and the severity of the condition into consideration, to terminate 355 pregnancy at the best time to prevent the occurrence of serious adverse maternal and 356 fetal outcomes. 357 358 It is also worth noting that the findings of the present study are subject to limitation of 359 missing data. We can hardly rule out the existence of missed case due to the pregnant 360 COVID-19 cases were identified based on the uploaded medical records. However, 361 we undertook a meticulous process in reviewing previous literatures and then believed 362 that the present study had the capability to capture a national picture of the impact of (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 23, 2021. Peking University Health Science Center (BMU2020HKYZX001). The mentioned 406 foundation had no rule in the study design, data analysis, drafting the manuscript, or 407 decision to submit this article for publication. 408 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 23, 2021. ; Oxygen support including nasal cannula, high flow oxygen and Invasive mechanical ventilation. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted October 23, 2021. ; World Health Organization. Coronavirus disease (COVID-19) Situation Report -410 164. Geneva: World Health Organization Characteristics and pregnancy outcomes of patients with 412 severe pneumonia complicating pregnancy: a retrospective study of 12 cases 413 and a literature review A pneumonia outbreak associated with a new 416 coronavirus of probable bat origin Why are pregnant women susceptible to 419 COVID-19? An immunological viewpoint Characteristics of Women of Reproductive Age 423 with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status -424 United States Coronavirus disease 2019 in pregnant women: a report 431 based on 116 cases Analysis of matched case-control studies Clinical Characteristics of COVID-19 Patients With 436 Digestive Symptoms in Hubei, China: A Descriptive Alterations in physiology and anatomy during pregnancy Phenotypic and metabolic 443 characteristics of monocytes and granulocytes in normal pregnancy and 444 maternal infection Liver injury in COVID-19: management and 447 challenges Relationship between pregnancy and 450 coronavirus: what we know COVID-19 infection among 453 asymptomatic and symptomatic pregnant women: Two weeks of confirmed 454 presentations to an affiliated pair of New York City hospitals Plasma inflammatory cytokines and 458 chemokines in severe acute respiratory syndrome Sarapultsev A, Sarapultsev P. Immunological environment shifts during pregnancy 464 may affect the risk of developing severe Reducing risks from coronavirus transmission in 468 the home-the role of viral load Viral load dynamics and disease severity in patients 471 infected with SARS-CoV-2 in Zhejiang province, China Severe maternal morbidity and 475 mortality associated with COVID-19: The risk should not be downplayed Maternal Death Due to 479 COVID-19 Disease Maternal deaths with coronavirus disease 482 2019: a different outcome from low-to middle-resource countries? Pregnant and postpartum women with 485 SARS-CoV-2 infection in intensive care in Sweden All rights reserved No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity Hemoglobin (g/liter) Median (IQR) * Percentages may not total 100 because of rounding. Covid-19 denotes coronavirus disease 2019, and IQR denotes interquartile range. † p<0 ‡ Oxygen support including nasal cannula, high flow oxygen and Invasive mechanical ventilation